Bluejay Diagnostics Stock Today
| BJDX Stock | USD 3.50 0.06 1.74% |
Performance0 of 100
| Odds Of DistressOver 81
|
Bluejay Diagnostics is trading at 3.50 as of the 22nd of November 2024; that is 1.74 percent increase since the beginning of the trading day. The stock's open price was 3.44. Bluejay Diagnostics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Bluejay Diagnostics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 10th of November 2021 | Category Healthcare | Classification Health Care |
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts. The company has 537.68 K outstanding shares of which 21.06 K shares are currently shorted by private and institutional investors with about 0.09 trading days to cover. More on Bluejay Diagnostics
Moving together with Bluejay Stock
Moving against Bluejay Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Bluejay Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBluejay Diagnostics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Bluejay Diagnostics' financial leverage. It provides some insight into what part of Bluejay Diagnostics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bluejay Diagnostics (BJDX) is traded on NASDAQ Exchange in USA. It is located in 360 Massachusetts Avenue, Acton, MA, United States, 01720 and employs 10 people. Bluejay Diagnostics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.85 M. Bluejay Diagnostics conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 537.68 K outstanding shares of which 21.06 K shares are currently shorted by private and institutional investors with about 0.09 trading days to cover.
Bluejay Diagnostics currently holds about 15.34 M in cash with (8.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76.
Check Bluejay Diagnostics Probability Of Bankruptcy
Ownership AllocationAlmost 97.91 percent of Bluejay Diagnostics outstanding shares are held by general public with 1.14 (percent) owned by insiders and only 0.95 % by other corporate entities.
Check Bluejay Ownership Details
Bluejay Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Renaissance Technologies Corp | 2024-09-30 | 137 K | |
| Anson Funds Management Lp | 2024-06-30 | 69.5 K | |
| Cvi Holdings Llc | 2024-06-30 | 66.2 K | |
| Virtu Financial Llc | 2024-06-30 | 17 K | |
| Warberg Asset Management Llc | 2024-06-30 | 12.5 K | |
| Tower Research Capital Llc | 2024-06-30 | 4.3 K | |
| Wells Fargo & Co | 2024-06-30 | 0.0 | |
| Sabby Management Llc | 2024-06-30 | 0.0 | |
| Armistice Capital, Llc | 2024-06-30 | 0.0 | |
| Advisor Group Holdings, Inc. | 2024-06-30 | 0.0 | |
| Xtx Topco Ltd | 2024-06-30 | 0.0 |
Bluejay Diagnostics Historical Income Statement
Bluejay Stock Against Markets
Bluejay Diagnostics Corporate Management
| Kenneth CPA | Chief Officer | Profile | |
| Kevin Vance | Chief Officer | Profile | |
| Jason Cook | Chief Officer | Profile | |
| Mark MD | Chief Advisor | Profile | |
| Les DeLuca | Vice Operations | Profile | |
| Eryn Graham | Marketing Manager | Profile |
Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.